CIK 0001434316
- Non-accelerated filer
- Smaller reporting company
FATE THERAPEUTICS INC
Sign in to watch- Ticker
- FATE
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 651311552
- Phone
- +1 858-875-1803
- Business address
- 12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA, 92131
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $13,525
- in 1 filing
Net −$13,525. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-22 | Wolchko J Scott President and CEO | Sale | −30,000 | $85.54 | $2.6M | 393,793 |
| 2021-04-22 | Wolchko J Scott President and CEO | Option exercise · Stock Option (right to buy) | −30,000 | 140,000 | ||
| 2021-04-16 | Chu Yu-Waye Senior VP Clinical Development | Sale | −875 | $81.80 | $72K | 67,200 |
| 2021-04-16 | Chu Yu-Waye Senior VP Clinical Development | Sale | −900 | $82.91 | $75K | 66,300 |
| 2021-04-16 | Chu Yu-Waye Senior VP Clinical Development | Sale | −1,500 | $84.41 | $127K | 64,800 |
| 2021-04-01 | TAHL CINDY See Remarks | Option exercise | +28,149 | $2.90 | $82K | 136,197 |
| 2021-04-01 | TAHL CINDY See Remarks | Option exercise | +1,851 | $7.87 | $15K | 138,048 |
| 2021-04-01 | TAHL CINDY See Remarks | Sale | −1,000 | $80.49 | $80K | 137,048 |
| 2021-04-01 | TAHL CINDY See Remarks | Sale | −8,220 | $81.48 | $670K | 128,828 |
| 2021-04-01 | TAHL CINDY See Remarks | Sale | −4,556 | $82.69 | $377K | 124,272 |
| 2021-04-01 | TAHL CINDY See Remarks | Sale | −3,490 | $83.40 | $291K | 120,782 |
| 2021-04-01 | TAHL CINDY See Remarks | Sale | −2,200 | $84.48 | $186K | 118,582 |
| 2021-04-01 | TAHL CINDY See Remarks | Sale | −4,835 | $85.98 | $416K | 113,747 |
| 2021-04-01 | TAHL CINDY See Remarks | Sale | −5,299 | $86.76 | $460K | 108,448 |
| 2021-04-01 | TAHL CINDY See Remarks | Sale | −400 | $87.45 | $35K | 108,048 |
| 2021-04-01 | TAHL CINDY See Remarks | Option exercise · Stock Option (Right to Buy) | −28,149 | 0 | ||
| 2021-04-01 | TAHL CINDY See Remarks | Option exercise · Stock Option Right to Buy | −1,851 | 10,458 | ||
| 2021-03-15 | Valamehr Bahram Chief Development Officer | Option exercise | −25,000 | $2.90 | $73K | 120,740 |
| 2021-03-15 | Valamehr Bahram Chief Development Officer | Sale | −3,957 | $90.89 | $360K | 116,783 |
| 2021-03-15 | Valamehr Bahram Chief Development Officer | Sale | −8,416 | $91.94 | $774K | 108,367 |
Page 21 of 26 · 503 trades